| Literature DB >> 34243801 |
Li Hua1, Quanhua Liu1, Jing Li1, Xianbo Zuo2, Qian Chen3, Jingyang Li1, Yuwei Wang4, Haipei Liu1, Zhaobo Shen5, Yi Li5, Zenan Ma6, Shengdong Dong7, Ruoxu Ji1, Dingzhu Fang1, Yi Chen1, Wenwei Zhong1, Jun Zhang3, Jianhua Zhang8, Yixiao Bao9,10.
Abstract
BACKGROUND: IL13, IL4, IL4RA, FCER1B and ADRB2 are susceptible genes of asthma and atopy. Our previous study has found gene-gene interactions on asthma between these genes in Chinese Han children. Whether the interactions begin in fetal stage, and whether these genes interact with prenatal environment to enhance cord blood IgE (CBIgE) levels and then cause subsequent allergic diseases have yet to be determined. This study aimed to determine whether there are gene-gene and gene-environment interactions on CBIgE elevation among the aforementioned five genes and prenatal environmental factors in Chinese Han population.Entities:
Keywords: Cord blood; Gene—environment interaction; Gene—gene interaction; IgE
Year: 2021 PMID: 34243801 PMCID: PMC8268446 DOI: 10.1186/s13223-021-00571-0
Source DB: PubMed Journal: Allergy Asthma Clin Immunol ISSN: 1710-1484 Impact factor: 3.406
Candidate genes and SNPs analyzed in this study
| Gene | SNP | rs Number | Chromosome position | Location |
|---|---|---|---|---|
| − 1112C > T | rs1800925 | 5:132,657,117 | Promoter | |
| + 1923C > T | rs1295686 | 5:132,660,151 | Intron 3 | |
| R110Q | rs20541 | 5:132,660,272 | Exon 4 | |
| − 590C > T | rs2243250 | 5:132,673,462 | Promoter | |
| R16G | rs1042713 | 5:148,826,877 | Exon1 | |
| − 109C > T | rs1441586 | 11:60,088,555 | Promoter | |
| E237G | rs569108 | 11:60,095,631 | Exon7 | |
| I75V | rs1805010 | 16:27,344,882 | Exon 5 | |
| Q551R | rs1801275 | 16:27,363,079 | Exon 12 |
SNP single-nucleotide polymorphism, rs reference SNP
Associations between CBIgE elevation and the epidemiologic characteristics of the study subjects
| Phenotypes | N (%) | Elevated rate of CBIgE | |
|---|---|---|---|
| Maternal age (y) | |||
| < 25 | 62 (6.4) | 17 (27.4) | 6.92 × 10–1 |
| 25–29 | 500 (51.9) | 128 (25.6) | |
| 30–34 | 325 (33.7) | 92 (28.3) | |
| ≥ 35 | 77 (8.0) | 24 (31.2) | |
| Maternal prepregnancy BMI (kg/m2) | |||
| < 18.5 | 150 (15.6) | 42 (28.0) | 5.79 × 10–1 |
| 18.5–24.9 | 694 (72.1) | 182 (26.2) | |
| 25–29.9 | 92 (9.6) | 29 (31.5) | |
| ≥ 30 | 26 (2.7) | 9 (34.6) | |
| Maternal education | |||
| Middle school or lower | 28 (2.9) | 6 (21.4) | 5.48 × 10–1 |
| High school | 112 (11.6) | 27 (24.1) | |
| College or higher | 825 (85.5) | 230 (27.9) | |
| Family income (CNY) | |||
| < 100 K | 273 (27.6) | 74 (27.1) | 9.98 × 10–1 |
| ≥ 100 K | 540 (54.6) | 146 (27.0) | |
| Unknown | 176 (17.8) | 48 (27.3) | |
| Maternal atopya | |||
| No | 824 (86.5) | 219 (26.6) | 2.17 × 10–1 |
| Yes | 129 (13.5) | 41 (31.8) | |
| Prenatal pet exposureb | |||
| No | 857 (89.1) | 234 (27.3) | 8.90 × 10–1 |
| Yes | 105 (10.9) | 28 (26.7) | |
| Prenatal active or secondhand smoking | |||
| No | 577 (59.9) | 158 (27.4) | 9.32 × 10–1 |
| Yes | 387 (40.1) | 105 (27.1) | |
| Parity | |||
| None | 868 (89.9) | 235(27.1) | 9.20 × 10–1 |
| ≥ 1 | 98 (10.1) | 27 (27.6) | |
| Previous pregnancy | |||
| None | 629 (65.1) | 169 (26.9) | 8.08 × 10–1 |
| ≥ 1 | 337 (34.9) | 93 (27.6) | |
| Gestational age (wk) | |||
| < 37 | 33 (3.4) | 7 (21.2) | |
| 37–39 | 686 (71.0) | 196 (28.6) | 2.70 × 10–1 |
| ≥ 40 | 247 (25.6) | 59 (23.9) | |
| Season of birth | |||
| Summer (Jun.—Aug.) | 170 (17.7) | 46 (27.1) | 4.90 × 10–1 |
| Autumn (Sep.—Nov.) | 451 (47.1) | 131 (29.0) | |
| Winter (Dec.—Feb.) | 337 (35.2) | 85 (25.2) | |
| Delivery mode | |||
| Vaginal | 229 (23.7) | 50 (21.8) | 3.93 × 10–2 |
| Cesarean section | 737 (76.3) | 212 (28.8) | |
| Gender | |||
| Boy | 499 (51.7) | 156 (31.3) | 2.28 × 10–3 |
| Girl | 466 (48.3) | 105 (22.5) | |
| Birth weight (g) | |||
| < 2500 | 24 (2.5) | 8 (33.3) | 7.86 × 10–1 |
| 2500–4000 | 857 (88.7) | 231 (27.0) | |
| ≥ 4000 | 85 (8.8) | 23 (27.1) | |
| Antenatal complicationsc | |||
| No | 763 (81.2) | 206 (27.0) | 6.26 × 10–1 |
| Yes | 177 (18.8) | 51 (28.8) | |
The missing data: maternal age (n = 25); maternal prepregnancy BMI (n = 27); maternal education (n = 24); maternal atopy (n = 36); prenatal pet exposure (n = 27); prenatal active or secondhand smoking (n = 25); parity (n = 23); previous pregnancy (n = 23); gestational age (n = 23); season of birth (n = 31); delivery mode (n = 23); gender (n = 24); birth weight (n = 23); antenatal complications (n = 49). The missing data were not from the same individuals for each variable
CBIgE cord blood IgE
aMaternal atopy was referred to those mothers who had asthma, allergic rhinitis or atopic dermatitis along with detectable specific IgE
bKeeping cats or dogs at home during pregnancy
cPregnancy hypertension, diabetes, infection or intrauterine growth retardation
*χ2 test was used to analyze associations between CBIgE elevation and the epidemiologic characteristics
Genetic effects of single SNPs on CBIgE elevation
| SNP | CBIgE levels | Risk allele | Risk allele frequency, n (%) | Genotype frequency AA/AB/BB n (%) | Dominant† | Recessive† | |
|---|---|---|---|---|---|---|---|
| CC/CT/TT | |||||||
| rs1800925 | Elevated | T | 102 (19.2) | 5.17 × 10–2 | 170(63.9)/90(33.8)/6(2.3) | 2.79 × 10–2 | 9.77 × 10–1 |
| Normal | 223 (15.5) | 1.29 (1.00–1.67) | 512(71.2)/191(26.6)/16(2.2) | 1.40 (1.04–1.88) | 1.01 (0.39–2.62) | ||
| GG/GA/AA | |||||||
| rs1295686 | Elevated | A | 204 (38.5) | 2.73 × 10–3 | 97(36.6)/132(49.8)/36(13.6) | 8.71 × 10–3 | 2.18 × 10–2 |
| Normal | 451 (31.3) | 1.37 (1.12–1.69) | 331(46.0)/327(45.4)/62(8.6) | 1.47 (1.10–1.97) | 1.67 (1.08–2.58) | ||
| CC/CT/TT | |||||||
| rs20541 | Elevated | T | 203 (38. 5) | 3.57 × 10–3 | 97(36.7)/131(49.6)/36(13.6) | 1.23 × 10–2 | 2.07 × 10–2 |
| Normal | 453 (31.5) | 1.36 (1.11–1.68) | 329(45.7)/329(45.7)/62(8.6) | 1.45 (1.08–1.94) | 1.68 (1.08–2.60) | ||
| TT/TC/CC | |||||||
| rs2243250 | Elevated | C | 109 (20.6) | 7.55 × 10–1 | 168(63.4)/85(32.1)/12(4.5) | 7.00 × 10–1 | 9.71 × 10–1 |
| Normal | 287 (19.9) | 1.04 (0.81–1.33) | 466(64.7)/221(30.7)/33(4.6) | 1.06 (0.79–1.42) | 0.99 (0.50–1.94) | ||
| AA/AG/GG | |||||||
| rs1042713 | Elevated | A | 296 (61. 7) | 1.41 × 10–1 | 97(40.4)/102(42.5)/41(17.1) | 8.81 × 10–2 | 5.94 × 10–1 |
| Normal | 763 (57.8) | 1.17 (0.95–1.46) | 226(34.2)/311(47.1)/123(18.6) | 0.77 (0.57–1.04) | 0.90 (0.61–1.33) | ||
| TT/TC/CC | |||||||
| rs1441586 | Elevated | C | 187 (35.4) | 3.41 × 10–1 | 108(40.9)/125(47.3)/31(11.7) | 3.82 × 10–1 | 5.10 × 10–1 |
| Normal | 477 (33.1) | 1.11 (0.90–1.37) | 317(44.0)/329(45.7)/74(10.3) | 1.14 (0.85–1.51) | 1.16 (0.74–1.81) | ||
| TT/TC/CC | |||||||
| rs569108 | Elevated | C | 91 (17.0) | 7.26 × 10–1 | 184(68.7)/77(28.7)/7(2.6) | 7.47 × 10–1 | 8.20 × 10–1 |
| Normal | 235 (16.3) | 1.05 (0.80–1.37) | 502(69.7)/201(27.9)/17(2.4) | 1.05 (0.78–1.42) | 1.11 (0.45–2.71) | ||
| GG/GA/AA | |||||||
| rs1805010 | Elevated | G | 274 (51. 9) | 3.22 × 10–1 | 72(27.3)/130(49.2)/62(23.5) | 3.84 × 10–1 | 4.59 × 10–1 |
| Normal | 708 (49.4) | 1.11 (0.91–1.35) | 176(24.5)/356(49.7)/185(25.8) | 0.87 (0.63–1.19) | 0.88 (0.63–1.23) | ||
| AA/AG/GG | |||||||
| rs1801275 | Elevated | A | 442 (83.4) | 6.66 × 10–1 | 178(67.2)/86(32.5)/1 (0.4) | 6.97 × 10–1 | 3.09 × 10–2 |
| Normal | 1189 (82.6) | 1.06 (0.81–1.38) | 493(68.5)/203(28.2)/24(3.3) | 1.06 (0.79–1.43) | 0.11 (0.01–0.82) |
SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval
*P Values for Pearson’s χ2 tests
†Dominant model (AA vs AB + BB) and recessive model (AA + AB vs BB), where A is the major allele and B is the minor allele
‡P Values for logistic analyses
Summary of gene–gene interactions for CBIgE elevation by GMDR analysis
| Interacting SNPs | TBA | |
|---|---|---|
| 0.5621 | 1.07 × 10–2 | |
| 0.5591 | 7.77 × 10–3 | |
| 0.5805 | 9.03 × 10–4 | |
| 0.5724 | 1.53 × 10–3 |
CBIgE cord blood IgE, GMDR generalized multifactor dimensionality reduction, SNP single-nucleotide polymorphism, TBA Testing balanced accuracy
Interactions between IL13 rs20541, IL13 rs1800925, IL4 rs2243250 and ADRB2 rs1042713 genotypes for CBIgE elevation
| Number of risk genotype for the four SNPs a | CBIgE levels | OR (95%CI) | ||
|---|---|---|---|---|
| Elevated, n (%) | Normal, n (%) | |||
| 0 | 31 (13.2) | 110 (16.8) | 1 | |
| 1 | 92 (39.1) | 265 (40.4) | 3.78 × 10–1 | 1.23 (0.78–1.96) |
| 2 | 71 (30.2) | 217 (33.1) | 5.42 × 10−1 | 1.16 (0.72–1.88) |
| 3 | 34 (14.5) | 58 (8.8) | 1.28 × 10–2 | 2.08 (1.16–3.72) |
| 4 | 7 (3.0) | 6 (0.9) | 2.69 × 10–2 | 4.14 (1.30–13.22) |
CBIgE cord blood IgE, SNP single-nucleotide polymorphism, OR odds ratio, CI confidence interval
aRisk genotypes were TT, CT/TT, TT, and AA for rs20541, rs1800925, rs2243250, and rs1042713, respectively
†P Values for χ2 tests
Interactions between the nine SNPs and maternal atopy for CBIgE elevation
| Gene | SNP | Minor allele | OR(95%CI) | |
|---|---|---|---|---|
| rs1800925 | T | 1.21 (0.86–1.71) | 2.81 × 10–1 | |
| rs1295686 | A | 0.89 (0.67–1.20) | 4.53 × 10–1 | |
| rs20541 | T | 0.91 (0.68–1.22) | 5.25 × 10–1 | |
| rs2243250 | C | 1.41 (1.04–1.91) | 2.65 × 10–2 | |
| rs1042713 | G | 0.86 (0.66–1.14) | 2.94 × 10–1 | |
| rs1441586 | C | 1.21 (0.91–1.59) | 1.91 × 10–1 | |
| rs569108 | C | 1.19 (0.84–1.69) | 3.19 × 10–1 | |
| rs1805010 | A | 0.89 (0.68–1.16) | 3.77 × 10–1 | |
| rs1801275 | G | 1.23 (0.88–1.72) | 2.31 × 10–1 |
SNP single-nucleotide polymorphism, CBIgE cord blood IgE, OR odds ratio, CI confidence interval
*P Values were tested by multivariate logistic regression, adjusted for other genes, but not for other environmental factors